Global Premature Ejaculation Treatment Market 2021-2025
SKU ID : TNV-17793457 | Publishing Date : 17-Mar-2021 | No. of pages : 120
Detailed TOC of Global Premature Ejaculation Treatment Market 2021-2025
• Executive Summaryo Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Route of Administration
o Market segments
o Comparison by route of administration
o Oral - Market size and forecast 2020-2025
o Topical - Market size and forecast 2020-2025
o Market opportunity by route of administration
• Market Segmentation by Drug Class
o Market segments
o Comparison by Drug Class
o SSRIs - Market size and forecast 2020-2025
o PDE5 inhibitors - Market size and forecast 2020-2025
o Amide anesthetics - Market size and forecast 2020-2025
o Others - Market size and forecast 2020-2025
o Market opportunity by Drug Class
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2020-2025
o Europe - Market size and forecast 2020-2025
o Asia - Market size and forecast 2020-2025
o ROW - Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Absorption Pharmaceuticals LLC
o Alembic Pharmaceuticals Inc.
o Amneal Pharmaceuticals Inc.
o Bayer AG
o Eli Lilly and Co.
o InvaGen Pharmaceuticals Inc.
o Pfizer Inc.
o Sandoz AG
o Solco Healthcare
o Teva Pharmaceutical Industries Ltd.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global - Market size and forecast 2020 - 2025 ($ million)
• 14: Global market: Year-over-year growth 2020 - 2025 (%)
• 15: Five forces analysis 2020 & 2025
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition - Five forces 2020
• 22: Other1 - Market share 2020-2025 (%)
• 23: Comparison by Other1
• 24: Oral - Market size and forecast 2020-2025 ($ million)
• 25: Oral - Year-over-year growth 2020-2025 (%)
• 26: Topical - Market size and forecast 2020-2025 ($ million)
• 27: Topical - Year-over-year growth 2020-2025 (%)
• 28: Market opportunity by Other1
• 29: Other2 - Market share 2020-2025 (%)
• 30: Comparison by Other2
• 31: SSRIs - Market size and forecast 2020-2025 ($ million)
• 32: SSRIs - Year-over-year growth 2020-2025 (%)
• 33: PDE5 inhibitors - Market size and forecast 2020-2025 ($ million)
• 34: PDE5 inhibitors - Year-over-year growth 2020-2025 (%)
• 35: Amide anesthetics - Market size and forecast 2020-2025 ($ million)
• 36: Amide anesthetics - Year-over-year growth 2020-2025 (%)
• 37: Others - Market size and forecast 2020-2025 ($ million)
• 38: Others - Year-over-year growth 2020-2025 (%)
• 39: Market opportunity by Other2
• 40: Customer landscape
• 41: Market share by geography 2020-2025 (%)
• 42: Geographic comparison
• 43: North America - Market size and forecast 2020-2025 ($ million)
• 44: North America - Year-over-year growth 2020-2025 (%)
• 45: Europe - Market size and forecast 2020-2025 ($ million)
• 46: Europe - Year-over-year growth 2020-2025 (%)
• 47: Asia - Market size and forecast 2020-2025 ($ million)
• 48: Asia - Year-over-year growth 2020-2025 (%)
• 49: ROW - Market size and forecast 2020-2025 ($ million)
• 50: ROW - Year-over-year growth 2020-2025 (%)
• 51: Key leading countries
• 52: Market opportunity by geography ($ million)
• 53: Impact of drivers and challenges
• 54: Vendor landscape
• 55: Landscape disruption
• 56: Industry risks
• 57: Vendors covered
• 58: Market positioning of vendors
• 59: Absorption Pharmaceuticals LLC - Overview
• 60: Absorption Pharmaceuticals LLC - Product and service
• 61: Absorption Pharmaceuticals LLC - Key offerings
• 62: Absorption Pharmaceuticals LLC - Key customers
• 63: Absorption Pharmaceuticals LLC - Segment focus
• 64: Alembic Pharmaceuticals Inc. - Overview
• 65: Alembic Pharmaceuticals Inc. - Product and service
• 66: Alembic Pharmaceuticals Inc. - Key offerings
• 67: Alembic Pharmaceuticals Inc. - Key customers
• 68: Alembic Pharmaceuticals Inc. - Segment focus
• 69: Amneal Pharmaceuticals Inc. - Overview
• 70: Amneal Pharmaceuticals Inc. - Business segments
• 71: Amneal Pharmaceuticals Inc. - Key offerings
• 72: Amneal Pharmaceuticals Inc. - Key customers
• 73: Amneal Pharmaceuticals Inc. - Segment focus
• 74: Bayer AG - Overview
• 75: Bayer AG - Business segments
• 76: Bayer AG - Key offerings
• 77: Bayer AG - Key customers
• 78: Bayer AG - Segment focus
• 79: Eli Lilly and Co. - Overview
• 80: Eli Lilly and Co. - Business segments
• 81: Eli Lilly and Co. - Key offerings
• 82: Eli Lilly and Co. - Key customers
• 83: Eli Lilly and Co. - Segment focus
• 84: InvaGen Pharmaceuticals Inc. - Overview
• 85: InvaGen Pharmaceuticals Inc. - Product and service
• 86: InvaGen Pharmaceuticals Inc. - Key offerings
• 87: InvaGen Pharmaceuticals Inc. - Key customers
• 88: InvaGen Pharmaceuticals Inc. - Segment focus
• 89: Pfizer Inc. - Overview
• 90: Pfizer Inc. - Business segments
• 91: Pfizer Inc. - Key offerings
• 92: Pfizer Inc. - Key customers
• 93: Pfizer Inc. - Segment focus
• 94: Sandoz AG - Overview
• 95: Sandoz AG - Product and service
• 96: Sandoz AG - Key offerings
• 97: Sandoz AG - Key customers
• 98: Sandoz AG - Segment focus
• 99: Solco Healthcare - Overview
• 100: Solco Healthcare - Product and service
• 101: Solco Healthcare - Key offerings
• 102: Solco Healthcare - Key customers
• 103: Solco Healthcare - Segment focus
• 104: Teva Pharmaceutical Industries Ltd. - Overview
• 105: Teva Pharmaceutical Industries Ltd. - Business segments
• 106: Teva Pharmaceutical Industries Ltd. - Key offerings
• 107: Teva Pharmaceutical Industries Ltd. - Key customers
• 108: Teva Pharmaceutical Industries Ltd. - Segment focus
• 109: Currency conversion rates for US$
• 110: Research Methodology
• 111: Validation techniques employed for market sizing
• 112: Information sources
• 113: List of abbreviations